Background. The i-gel
TM is a single-use supraglottic airway device (SAD) that allows fibreoptic-guided tracheal intubation through the device. Until now, no prospective data for this procedure are available. Therefore, in a prospective randomized controlled trial, we evaluated fibreoptic-guided tracheal intubation with a standard Rü sch TM PVC tracheal tube (TT) through the i-gel TM compared with the single-use ILMA TM (sILMA TM ) TT through the sILMA TM in patients with a predicted difficult airway.
Methods. With ethics committee approval and written informed consent, 160 patients were randomly assigned to either SAD. After placement of the SAD, a fibreoptic bronchoscope was introduced into the trachea as a railroad for the TT. Primary outcome variable was the first-attempt fibreoptic-guided intubation success rate. Secondary variables included time for insertion and intubation, airway leak pressures, fibreoptic view, and adverse events. Data are presented as mean (SD) or percentages. A P-value of ,0.05 was considered statistically significant.
Results. Fibreoptic-guided intubation was successful at the first attempt in 76 patients (96%) using the i-gel TM and in 71 patients (90%) using the sILMA TM (P¼0.21). Most of the failed intubations were rescued by conventional laryngoscopy. Airway leak pressure was higher for the sILMA TM . There were no problems during removal of either type of SAD.
Conclusions. Fibreopic-guided tracheal intubation through the i-gel TM using a standard Rü sch TM Magill TT is successful and an alternative to the sILMA TM with the sILMA TM TT.
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The i-gel TM (Intersurgical Ltd, Wokingham, Berkshire, UK) has proved popular with anaesthetists since its introduction into clinical practice. Its large airway diameter enables the introduction of a tracheal tube (TT) through the device. 1 2 The use of a fibreoptic scope has been recommended, but this has never been studied in a prospective randomized controlled trial in humans. The single-use intubating laryngeal mask airway (sILMA TM , The Laryngeal Mask Company Limited, Le Rocher, Victoria, Mahé, Seychelles) with its corresponding ILMA TM TT plays an important role in the emergency pathway of various difficult airway algorithms. 3 4 Success rate for tracheal intubation using the reusable ILMA TM is up to 93% with the aid of a fibreoptic scope. 5 Until now, there was only one trial in manikins 6 evaluating the performance of intubation through the i-gel TM compared with the reusable ILMA TM . The success rate of intubation through the ILMA TM is high, but so are the costs. Therefore, use of the ILMA TM in clinical practice may be limited to the unexpected difficult airway scenario. Clinicians initially may rely on the i-gel TM and then face the need to convert to a tracheal airway. In this case, they must know whether fibreopic-guided intubation through the i-gel is feasible. Therefore, in this prospective, randomized, controlled, patient-blinded trial, we compared fibreoptic-guided tracheal intubation through the i-gel TM using a conventional, curved Magill tracheal PVC tube (Super SafetyClear, Rü sch GmbH, Kernen, Germany) with the single-use ILMA TM (sILMA TM ) with its commercially available sILMA TM PVC TT. Our hypothesis was that there would be a difference of no more than 15% between the two supraglottic airway devices (SADs) for the first-attempt success rate of fibreopic-guided intubation. TM , and sILMA TM TT for i-gel TM ) before the fibreopic-guided intubation attempt was performed. The data from these last 40 patients are also included in an accompanying study. 10 The primary outcome was success rate of fibreoptic intubation at the first attempt. Airway management was performed under supervision of one of the senior study authors by staff anaesthesiologists with experience in the use of the i-gel TM , the ILMA TM , and in fibreoptic-guided tracheal intubation.
Methods

Participants and anaesthesia
All patients received midazolam 7.5 mg orally 30 min before induction of anaesthesia. After institution of recommended anaesthetic monitoring, anaesthesia was induced with propofol 1.0-2.5 mg kg 21 and fentanyl 2-3 mg
, and maintained with i.v. propofol to keep BIS 40-60. No neuromuscular blocking drugs were given before SAD insertion. After loss of the eye lash reflex, bag-mask ventilation was provided (maintaining Sp O 2 .96%, and steady values of endexpiratory ′ CO 2 ). Then, the lubricated i-gel TM or sILMA TM was introduced according to randomization group. A stable head position was obtained with a doughnut-shaped pillow throughout the study. The head was maintained in the neutral position for insertion of the sILMA TM and with the neck extended for insertion of the i-gel TM . After insertion of the SAD and completing all measurements related to the SAD, neuromuscular blocking drugs were administered to decrease the incidence of coughing during intubation, and to reduce complications during SAD removal.
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SAD insertion
SAD insertion was performed according to the manufacturer's recommendations 12 13 with small adjustments for size selection: a size 3 sILMA TM was chosen for patients weighing 30-50 kg, a size 4 for 50-70 kg, and a size 5 for patients .70 kg. For the i-gel TM , a size 3 was used for patients weighing 30-50 kg (up to 60 kg, if patient's height was ,160 cm), size 4 for 60-90 kg (down to 50 kg, if patient's height was .160 cm), and size 5 for patients .90 kg. This adaptation for the i-gel TM for patients in the weight range 50-60 kg was made to avoid the overlap between sizes 3 and 4. K-Y Lubricating Jelly (Johnson & Johnson Medical Limited, Gargrave, Skipton, UK) was used in all SADs. The cuff of the sILMA TM was fully deflated during insertion, and then inflated to a maximum of 60 cm H 2 O, 13 using a manometer (Rü sch TM GmbH, Kernen, Germany). An initial assessment of ventilation was made by gently squeezing the reservoir bag and observing end-tidal carbon dioxide waveforms and chest movements. In the case of adequate ventilation, leak pressure was measured as described below. Adequate ventilation was defined as two consecutive tidal volumes of at least 6 ml kg 21 ideal body weight (height in cm-100) during pressure-controlled ventilation at 17 cm H 2 O. 14 15 In the case of inadequate ventilation, up to three minor airway interventions were allowed (e.g. adjusting head/neck position, changing depth of insertion). 16 If the first SAD failed after three insertion attempts, the other SAD was used, again allowing three insertion attempts and minor airway manoeuvres.
14 Time necessary for insertion was measured from the time the face mask was taken away from the face until the appearance of CO 2 on the capnograph. inserted through the airway port. We graded best fibreoptic view on the glottis from the outlet of the SAD from 1 to 4 (1, vocal cords entirely visible; 2, vocal cords or arytenoid cartilages partially visible; 3, epiglottis only visible; 4, no laryngeal structures visible) as previously proposed. 17 After intubation with the fibrescope, the TT was railroaded into the trachea. To pass the epiglottic elevating bar in the case of the sILMA TM , the TT was inserted to the 15 cm depth mark (black line) and advanced beyond the epiglottic elevating bar of the sILMA TM together with the scope (tube first technique). Then, the larynx was seen and the fibreoptic scope was advanced into the trachea. The tip of the TT pointed upwards, so the black writing on the tube faced posteriorly. 13 To facilitate advancement of the TT over the fibreoptic scope, the following manoeuvres were permitted: anticlockwise rotation of the TT by 908, the SAD adjusted by 'Chandy' manoeuvres, 5 13 by the 'up-down' manoeuvre, or by changing the inclination of the patient's head. These adjustments of the SAD were also allowed if the fibrescope could not be inserted into the trachea, but not for the initial evaluation of fibreoptic view. 5 If fibreoptic intubation failed, either the alternative SAD was used or the airway was secured according to the attending anaesthesiologists decision. The position of the TT in the trachea was verified fibreoptically. Our primary outcome variable was the firstattempt success rate of fibreoptic-guided tracheal intubation. Success was defined as end-tidal carbon dioxide confirmed placement of the TT within a maximum of 5 min tracheal intubation time.
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After intubation, the fibrescope was removed and the breathing circuit reconnected to the tube. Intubation time was measured from the time the breathing circuit was disconnected until the carbon dioxide curve appeared again on the monitor. An additional time point was set when the glottis was passed with the scope (time necessary to intubate the trachea with the fibrescope).
To remove the SADs, we used the sILMA TM stabilizer rod for both SADs, according to the ILMA TM user booklet. 13 Time to remove the SAD was measured from disconnection of the breathing system until reappearance of the carbon dioxide curve on the monitor. At this time, the study was finished and anaesthesia was maintained according to the attending anaesthesiologist.
Airway leak pressure
Airway leak pressure was measured by closing the expiratory valve of the circle breathing system at a fixed gas flow of 3 litres min 21 and noting the airway pressure (max. allowed 40 cm H 2 O) at which equilibrium was reached or air was leaking audibly. 18 Air entering the stomach was detected by auscultation over the epigastrium when measuring oropharyngeal leak. 14 
Adverse events
All adverse events were recorded, defined as suspicion of aspiration/regurgitation (gastric fluid in the ventilation tube or in the hypopharynx), hypoxia (SpO 2 ,92%), hypotension (mean arterial pressure ,55 mm Hg), hypertension (mean arterial pressure ±20% over pre-induction baseline), changes in heart rate ±20%, pre-induction value, bronchospasm, airway obstruction, coughing, dental, tongue, or lip trauma.
Evaluation of postoperative complaints
On postoperative day 1, an investigator who was blinded to patient allocation, anaesthesia, and the performance of airway management interviewed the patient to obtain data about side-effects. In the case of ambulatory surgery, we called the patients by phone. Asked items included: sore throat, hoarseness, dysphagia, postoperative nausea and vomiting, rescue medication, pain, analgesics taken, and any unscheduled re-hospitalization.
Statistical analysis
There are no clinical trials prospectively evaluating fibreoptic intubation through the i-gel TM SAD in humans. Joo and Rose
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showed a 93% first-attempt success when intubating through the ILMA TM using a fibreoptic scope. Pandit and colleagues 19 had an 80% first-attempt success when fibreopticguided intubation was performed via the classic LMA and an outright failure of 10% because of the aperture bars. A clinically significant difference in success of 15% was assumed in a study (ILMA TM vs C-Trach TM ) by Liu and colleagues 20 in accordance with the data of Pandit and colleagues 19 who found a difference of 15% comparing fibreoptic intubation through ILMA TM vs the classic LMA TM . On the basis of our experience with the i-gel TM , we expected the difference of the fibreoptically guided tracheal intubation success rate to be ,15%, and calculated that a sample of 160 patients was necessary, given a¼0.05 and a power of 80%.
For our primary outcome variable, the success rate of fibreoptic-guided tracheal intubation, and other frequency data, we compared values using the x 2 test. The SADs were evaluated as intention-to-treat according to randomization. Continuous data were analysed using the Mann -Whitney test if normality distribution could not be assumed; otherwise Student's t-test was used. We analysed all data with SPSS V.15 (SPSS Inc., Chicago, IL, USA/SPSS Schweiz AG, Zü rich, Switzerland). Data are presented as mean (SD), or percentage. A probability value of ,0.05 was considered statistically significant.
Results
One hundred and sixty-five patients were undergoing general anaesthesia with tracheal intubation and presented at least one predictor of difficult airway management during the 349 days of the study. Four patients did not give informed consent. One was not randomized because of changes in surgical procedure, and so 160 patients were randomized, 91 (57%) of whom were male (Fig. 1) . Twenty-two anaesthetists participated in the study. There were no differences in baseline patient characteristics (Table 1) .
Fibreoptic intubation through i-gel TM and sILMA TM BJA Face-mask ventilation was deemed to be easy in 108 cases, in the other 52 cases either two-handed ventilation or a Guedel airway was necessary. Vital signs did not differ significantly between the two SADs throughout the study.
Insertion of the SADs
We found no difference in the insertion success rates between i-gel TM and sILMA TM (P¼1.00, Table 2 ). In one case of insufficient ventilation with an sILMA TM , the airway was secured by oral intubation. One i-gel TM failed because of inadequate ventilation without hypoxia. This patient's lungs were ventilated successfully using the sILMA TM . One i-gel TM had to be changed from size 4 to 5 in a male patient of 88 kg and 173 cm and one sILMA TM had to be changed from size 4 to 5 in another male of 67 kg and 174 cm because of excessive airway leaks, although the size selection was according to the manufacturer's descriptions.
There were no differences in first-attempt success rates and rate of minor interventions necessary ( 
Fibreoptic tracheal intubation
Ventilation failed with one i-gel TM and one sILMA TM and the airway had to be secured by other means. Fibreoptic intubation was attempted via 79 i-gels TM and 79 sILMAs TM . There was no statistically significant difference in the primary outcome measure: the success rate at first attempt of fibreoptically guided tracheal intubation was 76 (96%) using the i-gel TM with the Magill PVC TT compared with 71 (90%) using the sILMA TM with its sILMA TM TT (P¼0.21, Table 3 ).
There was no difference in fibreoptic laryngeal view (P¼0.42). Epiglottic downfolding was more frequent in the sILMA TM compared with the i-gel TM (16% vs 1%, P¼0.01). The mean time necessary for intubation was 72 (42) s for the i-gel TM group and 65 (37) s for the sILMA TM group (P¼0.34). The time necessary for the fibrescope to intubate the trachea did not differ significantly between i-gel and sILMA TM (P¼0.54). However, the time to railroad the tubes over the fibrescopes varied greatly between the two SADs [i-gel TM : mean 28 (17) s, sILMA TM : mean 18 (15) s, P,0.001]. The three patients in the i-gel TM group in whom fibreoptic intubation was impossible despite correction manoeuvres all underwent tracheal intubation using conventional laryngoscopy. The eight failed sILMA TM intubations were managed by conventional intubation seven times and once by fibreoptic intubation through the i-gel TM (Fig. 1) .
Removal of the SAD
All inserted SADs were removed without complications using the sILMA TM exchange rod. There was no difference in removal time between the SADs [39 (13) s for the i-gel 
Adverse events and postoperative complaints
We found no differences in haemodynamic changes during insertion or intubation between the groups. Four i-gels 
Discussion
In this prospective, randomized, controlled, patient-blinded clinical trial, we found equally high success rates for fibreopic-guided tracheal intubation with the Rü sch TM Magill TT via the i-gel TM , and with the single-use ILMA TM TT via the sILMA TM in a patient population with predictors of difficult airway management.
The fibreoptic-guided intubation with the Rü sch TM Magill TT through the i-gel TM failed in only 4%. The 90% success rate for the sILMA TM group was slightly lower than the 93% described earlier for the reusable ILMA TM . 5 This might be attributed to our study population presenting predictors of difficult airway management or to the different material of the single-use ILMA TM (PVC) and the reusable ILMA TM (silicone). However, an earlier comparison of the reusable and the single-use ILMA TM in 84 patients with normal airway anatomy found the performance of both devices to be equal. 21 The few failed fibreoptic intubations were evenly distributed among the anaesthesiologists and we did not find an influence of the anaesthesiologist on the time necessary for intubation. Also, our post hoc analysis detected no decrease in intubation time over the study course, indicating the absence of a learning curve. There was no statistically significant difference in the intubation success rate between i-gel TM and sILMA TM (96% vs 90%, P¼0.211). The 95% confidence interval of this difference in success rate was 22% to 15%. We do not know to what extent the success rate would have changed if we had used an sILMA TM TT with the i-gel TM , but this was not the goal of the study. The differences in success rates using different TTs with the ILMA TM have been studied by others, with inconclusive results. 5 22-24 It took longer to railroad the Rü sch TM Magill PVC TT over the intubated fibrescope. We speculate that the softer tip of the sILMA TM TT allowed easier advancement. 25 Our study confirmed the high airway seal pressures for both SADs which were published by other study groups. 5 26 Airway leak pressures for the sILMA TM were higher than previously reported for the reusable ILMA TM . 27 Postoperative complaints were rare and we did not find any statistically significant differences between the two airway sets. However, there was a statistically not significant difference in the incidence of postoperative sore throat with the i-gel TM /Rü sch TM PVC TT (14%) compared with the sILMA TM /sILMA TM TT (9%, P¼0.45). Both the stiffness of the Rü sch TM PVC TT and the i-gel TM may have been contributing factors.
As a limitation, this study was performed on patients with predictors of difficult mask ventilation, difficult laryngoscopy, and difficult intubation. Because of ethical considerations, we did not include patients with a previously known difficult airway, denying them the advantage of an awake fibreoptic intubation. It is possible that the devices used in the present study perform differently in patients with real difficult airway, but that was not in the scope of this study.
In the last 40 patients, a visualized blind intubation attempt was performed before fibreoptic intubation (these data are included in an accompanying study). 10 This TT was withdrawn, and the patients were intubated by fibreoptic guidance according to the randomized airway device. To rule out any potential effect of the blind intubation attempt on the later fibreoptic intubation, we compared both subgroups (the last 40 patients vs the first 120 patients) and found no difference in time for fibreoptic intubation (P¼0.12 for the i-gel TM and P¼0.38 for the sILMA TM ). There was no significant difference in failure rate: 1.6% (i-gel TM ) and 5% (sILMA TM ) in the first 120 patients compared with 2.5% (i-gel TM ) and 5% (sILMA TM ) in the last 40 patients (P¼0.99). In conclusion, we found that in 160 patients with predictors for difficult airway management, fibreoptic-guided tracheal intubation with a standard Rü sch TM Magill PVC TT through an i-gel TM was as successful as the use of an sILMA TM with its sILMA TM TT. The i-gel TM and Rü sch TM Magill TT may be a reliable and cost-effective alternative to the sILMA TM with its sILMA TM TT.
